Important Announcements

Nondiscrimination Statement Update

Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.

To see our full nondiscrimination statement, click here.

Campus Construction Update

Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience. 

Click here to learn more about our campus redesign. 

The Grayken Center also launches the Richard Saitz Addiction Medicine Editorial Internship and “Behind the Evidence” podcast

BOSTON – The Grayken Center for Addiction at Boston Medical Center (BMC) is pleased to announce the acquisition of Alcohol, Other Drugs, and Health: Current Evidence (AOD Health; www.aodhealth.org). Established in 2004, AOD Health is a free, bi-monthly, non-commercial newsletter providing summaries of and expert commentary on recent clinically relevant articles from addiction research literature for a general medicine audience. For the last 18 years, AOD Health has been supported by BMC’s Clinical Addiction Research and Education (CARE) National Institute on Drug Abuse R-25 grant.

The Grayken Center’s Medical Director, Miriam Komaromy, MD, stepped into the role of co-Editor-in-Chief of AOD Health, alongside longtime co-Editor-in-Chief, David Fiellin, MD, director, Program in Addiction Medicine, Yale New Haven Health. Fiellin formerly shared the role with the late Dr. Richard Saitz.

“The Grayken Center and AOD Health are ideal partners, aligned in their missions to improve patient care by increasing healthcare providers’ confidence and competence in identifying and treating substance use disorders,” Dr. Komaromy said.

 “AOD Health’s move to the Grayken Center after nearly two decades of NIH support ensures its longevity and provides opportunities to expand the partnership’s reach and impact in the dissemination of clinical addiction research and education,” said former co-Editor-in-Chief Jeffrey Samet, MD,  general internal medicine, BMC.

In partnership with the American College of Academic Addiction Medicine (ACAAM), AOD Health is launching the Richard Saitz Addiction Medicine Editorial Internship this month, led by Darius Rastegar, MD, medical director, Inpatient Chemical Dependence Unit, Johns Hopkins Bayview Medical Center. Named for the longtime editor of AOD Health and open to Addiction Medicine fellows, this nine-month program provides mentorship and experience in publishing addiction science. Applications are being accepted now until August 31, 2022. There will be one editorial intern in 2022-23, with the possibility for more in coming years.

Further expanding the reach of AOD Health is the forthcoming “Behind the Evidence: the addiction medicine podcast.” Hosted by Marc Larochelle, MD, MPH, primary care, BMC and Honora Englander, MD, director, Improving Addiction Care Team, Oregon Health & Science University, the podcast will summarize and contextualize recent peer-reviewed addiction medicine literature. Additional episodes will include author interviews and a deeper dive into selected articles summarized in AOD Health. The first episodes of “Behind the Evidence” will be released in the fall.

Media Contact:

communications@bmc.org
Return to BMC News